The Scientist

» gene therapy, neuroscience and immunology

Most Recent

image: Book Excerpt from <em>Wondrous Truths</em>

Book Excerpt from Wondrous Truths

By | June 1, 2016

In Chapter 2 author J.D. Trout highlights the dividing line between truth and scientific “fact.”

0 Comments

image: Contributors

Contributors

By | June 1, 2016

In Chapter 2 author J.D. Trout highlights the dividing line between truth and scientific “fact.”

0 Comments

image: Enhancing Vaccine Development

Enhancing Vaccine Development

By | June 1, 2016

In Chapter 2 author J.D. Trout highlights the dividing line between truth and scientific “fact.”

1 Comment

image: Meet An Artist With No Hands

Meet An Artist With No Hands

By | June 1, 2016

In Chapter 2 author J.D. Trout highlights the dividing line between truth and scientific “fact.”

0 Comments

In Chapter 2 author J.D. Trout highlights the dividing line between truth and scientific “fact.”

0 Comments

image: Zebra Finches Aid Neurodegeneration Research

Zebra Finches Aid Neurodegeneration Research

By | June 1, 2016

In Chapter 2 author J.D. Trout highlights the dividing line between truth and scientific “fact.”

0 Comments

image: Toward Targeted Therapies for Autoimmune Disorders

Toward Targeted Therapies for Autoimmune Disorders

By | June 1, 2016

In Chapter 2 author J.D. Trout highlights the dividing line between truth and scientific “fact.”

2 Comments

image: Pioneering Memory Researcher Dies

Pioneering Memory Researcher Dies

By | May 31, 2016

In Chapter 2 author J.D. Trout highlights the dividing line between truth and scientific “fact.”

0 Comments

In Chapter 2 author J.D. Trout highlights the dividing line between truth and scientific “fact.”

0 Comments

image: FDA Approves Bladder Cancer Immunotherapy

FDA Approves Bladder Cancer Immunotherapy

By | May 23, 2016

In Chapter 2 author J.D. Trout highlights the dividing line between truth and scientific “fact.”

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech